IVIG (Intravenous Immunoglobulin)

BIOLOGICAL4 trials

Conditions

Alloimmune ThrombocytopeniaFetal Alloimmune ThrombocytopeniaLong COVIDLong Coronavirus Disease 2019 (Covid19)Long Covid-19MMNMultifocal Motor Neuropathy (MMN)Myasthenia Gravis (MG)

Phase 2

A Trial of Antenatal Treatment of Alloimmune Thrombocytopenia

CompletedNCT00194987

Weill Medical College of Cornell UniversityAlloimmune Thrombocytopenia, Fetal Alloimmune Thrombocytopenia

Start: 2001-04-30End: 2015-06-30Updated: 2018-11-07

RECOVER-AUTONOMIC: Platform Protocol, Appendix A (IVIG)

CompletedNCT06305793

Kanecia Obie ZimmermanLong Coronavirus Disease 2019 (Covid19), Long COVID, Long Covid-19

Start: 2024-05-08End: 2026-06-22Updated: 2026-07-31

Phase 3

A Study to Assess the Efficacy and Safety of Empasiprubart Versus IVIg in Adults With Multifocal Motor Neuropathy

Active, not recruitingNCT06742190

argenxMMN, Multifocal Motor Neuropathy (MMN)

Start: 2024-12-18End: 2029-12-01Updated: 2026-05-20

Unknown Phase

Efficacy of IVIG Versus PLEX in Myasthenic Crisis in Syria.

CompletedNCT07532707

Damascus UniversityMyasthenia Gravis (MG), Myasthenic Crisis

Start: 2022-09-01End: 2023-10-30Updated: 2026-04-16

Related Papers

P1592: EFFECTS OF FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA (FNAIT) ON NEONATAL BIRTHWEIGHT: AN ANALYSIS USING SIBLING PAIRS

HemaSphere2023-08-01

Blood group A mothers are more likely to develop anemia during antenatal intravenous immunoglobulin treatment of fetal and neonatal alloimmune thrombocytopenia.

2016-09-097 citations

Antepartum treatment without early cordocentesis for standard-risk alloimmune thrombocytopenia: a randomized controlled trial.

2007-08-0145 citations